Wiley Joins U.S. Department of Energy’s Genesis Mission Consortium to Advance AI-Powered Scientific Discovery Wiley announced its membership in the Genesis Mission Consortium, the public-private partnership supporting the U.S. Department of Energy’s (DOE) Genesis Mission, joining organizations including Nvidia, AWS,…
Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000 Immunomic Therapeutics, Inc. a clinical-stage biotechnology company and a U.S.-based subsidiary of HLB, announced that the first participant has been dosed in the Phase 1…
illumiSonics and Sunnybrook Launch INOVAIT Focus Fund–Backed Clinical Trial Bringing Label-Free Laser Histology to Mohs Skin Cancer Surgery illumiSonics Inc., a medical technology company commercializing label-free tissue imaging, announced the launch of a prospective clinical validation study at Sunnybrook Health…
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA Bristol Myers Squibb a global biopharmaceutical leader, announced it will expand its compute infrastructure to deploy an NVIDIA DGX SuperPOD with DGX Vera Rubin NVL72…
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older Almirall, S.A. a global biopharmaceutical company focused on medical dermatology, today announced that the European Medicines Agency (EMA) has…
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 2026 Meiji Seika Pharma Co., Ltd. announced that results from the global Phase III…
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies Takeda announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and…
IQVIA’s Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States IQVIA a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare…
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System Medifast, Inc. announced the launch of Trilivy, a comprehensive metabolic health system uniquely designed to support healthy lifestyle change. The launch also introduces newly formulated meal replacements, including the Trilivy…
Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T…
Tavoron Expands Automation Capabilities with Acquisition of Fluidraulics Tavoron, a national leader in industrial automation, robotics, compressed air, motion control and engineered solutions, announced the acquisition of Fluidraulics Inc., an automation component and system distributor that has served customers across…
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches Charles River Laboratories International, Inc. announced a collaboration with Arovella Therapeutics Ltd a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS)…